Cardiovascular Systems (CSII) Misses Q3 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Leerink Partners Raises Price Target as Cardiovascular Systems (CSII) Reports Above Preannouncement
May 5, 2016 8:52 AM EDTLeerink Partners reiterated a Market Perform rating on Cardiovascular Systems (NASDAQ: CSII), and raised the price target to $15.00 (from $13.00), following the company's 3Q earnings report. CSII reported sales of $44.5M, slightly above its preannounced range of $43.5M-$44M. Leerink continues to view CSII's longterm... More
Cardiovascular Systems (CSII) Offers Three-Year Data from Pivotal ORBIT II Study
May 5, 2016 8:08 AM EDTCardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) shared three-year results from its pivotal ORBIT II study in a featured clinical research presentation at the 2016 Society for Cardiovascular Angiography and Interventions (SCAI) conference in Orlando, Florida.
The ORBIT II study evaluated the safety and efficacy of the companys Diamondback 360® Coronary Orbital Atherectomy System... More
